SBIR/STTR Research Award

Development of a syringe/sonication device employed to administer DDFPe in the prehospital setting

Award identifier ff4e0c1343e64dccbfd0d38bfed0bc3aaba1af028ea0f64f6eed6818f4872c22Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$143,988

Program and phase

SBIR · Phase I

Award year

2018

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
NUVOX PHARMA, L.L.C.
Proposal award date
2017-12-01
Contract end date
2019-05-31
UEI
WHNYG96UDLJ8
Solicitation number
PA16-302
Topic code
101

Research abstract

PROJECT SUMMARY ABSTRACT Clinical ChallengeIn acute traumain the civilian settinghemorrhage is the second most leading cause of deathIn the military settingof potentially preventable deaths are caused by hemorrhage due to traumaof civilian andof military mortality caused by traumatic hemorrhage occurs pre hospitalizationAdverse outcome in trauma patients during prehospital resuscitation is due to the unavailability of blood transfusions in the field leading to insufficient oxygenationTraumatic brain injuryTBIis the leading cause of disability in both civilians and militarySpecificallyin the pre hospital settinghypoxia in TBI may be the most important secondary injury affecting mortalityA therapy that can be deployed rapidlyand safely en route to the hospital in the civilian and the battlefield settings could greatly reduce the trauma mortality rates due to both hemorrhage and TBIWe are developing an oxygen therapeuticdodecafluoropentane emulsionDDFPewhich has the potential to be administered in the prehospital settingThis could greatly prolong the time window for administration of follow on therapies to trauma patientsthus increasing the likelihood of successful recoveryAll fluorocarbon emulsions undergo a gradual increase in particle size due to Ostwald ripeningDDFPe has a two year shelf life atCabout one year at room temperature and shorter shelf life at higher temperatures due to particle size increase beyond specificationsWe have discovered a means of maintaining the particle size of DDFPe within specification that affords at least a two year shelf life even under potentially extreme conditionsAvailability of an oxygen therapeutic in field conditions would allow it to be used in emergent settings maintaining vital oxygenation in civilian and military traumaOverarching HypothesesSonication of pre filled syringes of DDFPe can be employed to produce in spec nanoemulsion suitable for IV administrationUltimatelybattery poweredportableeasy to use pre filled syringe sonication systems can be developed for field based applicationsSpecific AimsDemonstration of optimal acoustic parametersDemonstration that product composition is not affected by sonicationExpected OutcomeSuccessful completion of the study will determine the optimal ultrasound parameters to enable design of a portablebattery powered syringe sonication device in Phase II of this development program A therapy that can be deployed rapidlyand safely en route to the hospital for civilians and also for soldiers on the battlefield could greatly reduce the trauma mortality rates due to both hemorrhage and traumatic brain injurySonication of pre filled syringes of dodecafluoropentane emulsionDDFPean oxygen therapeuticcan be employed to produce in spec nanoemulsion suitable for IV administrationUltimatelya battery poweredportableeasy to usepre filled syringe sonication system can be developed for DDFPe administration in the pre hospital setting

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

12 SBIR/STTR records share this UEI (2010–2025). Reported award amounts total $8,518,151. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.